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Available online 6 October 2016AbstractObjectives: The purpose of the study was to assess the effectiveness of the Fracture Liaison service (FLS) in preventing secondary fracture and
decreasing 1-year mortality rate after osteoporotic hip fracture, in patients at Police General Hospital, Bangkok, Thailand.
Methods: A prospective cohort study was conducted. We studied male and female patients, 50 years of age and older, who presented with a
fragility fracture around the hip due to low energy trauma and were admitted to Police General Hospital, participating in PGH's Liaison service
from April 1, 2014eMarch 30, 2015. The sample size was 75 patients, with a follow up time of 1 year. The data from this study was compared
with that of a previous study done by Tanawat A. et al. [9] prior to commencement of the FLS project.
Results: After a follow up period of 1 year, the mortality rate was measured to be 10.7% and there was no evidence of secondary fragility fracture.
Post-injury bone mineral density follow up and osteoporotic medication treatment rates were 48% and 80%, respectively. Patients who participated
in the project were found to have a decreasing rate of secondary fracture from 30% to 0% (P< 0.0001), an increasing post-injuryBMD follow up rate
from 28.3% to 48% (P¼ 0.0053), and an increase in post-injury osteoporotic medication administration rate from 40.8% to 80% (P¼ 0.0148), all
with statistical significance. However, the 1-year mortality rate was not significant (P ¼ 0.731) when compared to the previous study.
Conclusions: Patients with recent hip fractures participating in the Fracture Liaison service had a significantly higher post-injury BMD follow up
and osteoporotic medication administration rates. This resulted in a lower risk of secondary fracture than those who did not participate in the
Fracture Liaison service at a follow up time of one year.
© 2016 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Osteoporosis is defined as a generalized disorder of the
skeleton characterized by low bone mass and alterations of
bone tissue microarchitecture, leading to an increased risk of
bone fragility fracture, especially in postmenopausal women.
Recently, the prevalence of elderly patients with osteoporosis
is increasing in Thailand and worldwide, resulting in an in-
crease in fragility fracture.* Corresponding author. Department of Orthopedics, Police General Hospital,
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).This has become a large public health care issue as the
fracture events have increased morbidity and mortality as well
as altered the patients' quality of life, particularly in the first
year after injury. Furthermore, patients with an incident frac-
ture have an increased risk of refracture [1]. Data from a study
in Korea (Y.K. Lee et al.) found that first year mortality rate in
osteoporotic hip fracture is 15.4% and 11.1% in men and
women, respectively. They also found that for osteoporotic
vertebral fracture in men and women the rates were 14.6% and
7.16%, respectively [2,3]. Another study conducted in Chiang
Mai, Thailand (P. Wongtriratanachai et al.) found that first year
mortality in hip fracture is approximately 18e20% [4]. A
study conducted in Finland (E. Lonnroos et al.) displayed datalsevier B.V. This is an open access article under the CC BY-NC-ND license
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second year are 5.08% and 8.11%, respectively [5]. Currently
assessment rates for secondary prevention of osteoporosis are
low [6e8], with a substantial gap existing between known
evidence-based therapy and clinical practice.
Although our hospital (Police General Hospital) has pre-
viously had a specific set of guidelines for osteoporotic
treatment according to the Thai Osteoporosis Foundation
(TOPF) since 2011, the osteoporotic hip fracture patients still
received inadequate treatment and had a high incidence of
mortality and secondary fracture at 1 year after fracture. From
data of a previous study conducted by Tanawat A. et al., it was
found that the mortality rate, secondary fracture occurrence
and follow up of bone mineral density at 1 year after initial
fracture were 9.2%, 30%, and 28.33% respectively. It was also
shown that osteoporotic treatment 1 year after initial fracture
with calcium and vitamin D, non-bisphosphonate drugs and
bisphosphonate drugs were 20.83%, 15%, and 5% respec-
tively. Follow-up of the patients one year after fracture was
found to be less than 2% [9].
Previously, the International Osteoporotic Foundation
(IOF) has established a Fracture Liaison service named
‘Capture the fracture’ in 2012 intended to prevent secondary
fracture by facilitating the implementation of Fracture Liaison
Services (FLS) by increasing communication and cooperation
which results in a close working relationship between
personnel and organizations in order to provide appropriate
osteoporotic treatment, fall risk assessment, and post-
treatment exercise and education programs. Many studies
have shown that after implementing the Fracture Liaison ser-
vice, there was a significantly decreasing mortality rate and re-
fracture rate [10], as well as an increasing rate of osteoporotic
treatment following standard guidelines [11,12]. Up until now,
previously no other hospitals in Thailand other than Police
General Hospital have implemented a Fracture Liaison service
for specific patient group care and assessment of its
effectiveness.
The purpose of the study was to assess the effectiveness of
the Fracture Liaison service in decreasing 1st year secondary
fracture rate and mortality rate, and increasing osteoporotic
hip fracture treatment in Police General Hospital (PGH).
2. Methods
A prospective single-center cohort study was conducted.
We studied male and female patients, 50 years of age and
older, who presented with fragility fracture around the hip due
to low energy trauma (defined as a fall from a standing height
or lesser impact) that had been admitted to Police General
Hospital and participated in PGH's Liaison service from April
1, 2014eMarch 30, 2015. The sample size was 75 patients,
with a follow up time of 1 year. Exclusion criteria were pa-
tients who had a fracture due to high energy trauma, secondary
osteoporosis (e.g. chronic kidney disease-mineral and bone
disorders; CKD-MBD) and bone tumors (Fig. 1).
Demographic data were collected using a standardized
questionnaire for each patient at baseline: sex, age, underlyingdisease, type of fracture, previous fragility fracture history,
current osteoporotic medication, type of fracture treatment,
and history of BMD evaluation.
The primary outcomes were the evaluation of secondary
fragility fracture and mortality rate after one year of participa-
tion in this project. Secondary outcomes measured included
bone mineral density (BMD) follow up and administration of
osteoporotic medication after fragility fracture. This article was
approved by Ethic review committee for Human research, Po-
lice General Hospital, Bangkok, Thailand (COA No.15/2015).
Statistical analysis with a p-value of <0.05 for statistical
significance was performed. Continuous data were presented
as maximum, minimum, mean and standard deviation. Cate-
gorical data were presented as a proportion. 95% CI was used
to select factors.
3. Result
We had 100 osteoporotic hip fracture patients participating
in Police General Hospital's Fracture Liaison Service (PGH's
Liaison). We classified 89 as fragility fracture patients (pri-
mary osteoporotic fracture) and 11 as secondary osteoporotic
patients (10 CKD-MBD, and one bone tumor case). After one
year, we had a remaining number of 75 patients for inclusion
in this study due to loss of follow up. All included patients
were able to follow the project's protocol (Fig. 2).
4. Demographic data
The demographics of the patients who met the eligibility
criteria are summarized in Table 1. There were 63 females
(84%) and 12 males (16%). The average age was 79.7 years
old (females 80.6 years old; males 74.3 years old) and the
maximum and minimum ages were 97 and 51, respectively.
Thirty-four patients (45.3%) were older than 80 years. The
most common chronic underlying illnesses were hyperten-
sion in 56 patients (74.7%), diabetes mellitus in 27 patients
(36%), and dyslipidemia in 21 patients (28%). Thirty-five
patients (46.7%) had femoral neck fractures, 38 patients
(50.7%) had intertrochanteric fractures and 2 patients (2.6%)
had greater trochanteric fractures. Twelve (16%) patients
had previous fragility fractures. Sixty-four patients (85.3%)
underwent operative treatment, whereas the remaining 11
patients (14.7%) were treated non-operatively. The common
reason for non-operative management was severe associated
medical conditions. Operative treatment was divided in two
types; fixation or arthroplasty and patient selection for each
type was done according to fracture type. For treatment by
fixation, 25 cases (33.3%) were treated by proximal femoral
nail antirotation (PFNA) fixation, 7 cases (9.3%) were
treated by dynamic hip screw fixation, and 3 cases (4%)
were treated by multiple screw fixation. For treatment by
arthroplasty, 27 cases (36%) were treated by hemi-
arthroplasty and 2 cases (2.7%) were treated by total hip
arthroplasty. Seventeen patients (22.7%) received calcium
supplementation alone, 14 patients (18.7%) received calcium
and vitamin D supplementation, 4 patients (5.3%) received
Fig. 1. Study population flow diagram.
240 T. Amphansap et al. / Osteoporosis and Sarcopenia 2 (2016) 238e243antiresorptive agents and 2 patients (2.7%) received anabolic
agents prior to initial fracture (Fig. 3). Only 7 patients
(9.3%) had undergone pre-injury bone mineral density
(BMD) evaluation. We compared all demographic data with
the previous study done prior to the FLS project by Tanawat.
A et al. [9], and found no statistically significant differences
(P > 0.05).
At 1 year after the implementation of the Fracture Liaison
Service, 8 patients were deceased (10.7%), with 2 from the
non-operative group and 6 from the operative group. No evi-
dence of secondary fragility fracture after 1st year follow-up
was seen. Sixty patients (80%) were being treated with oste-
oporotic medication after a follow-up period of approximately
1 year. We classified treatment as calcium or vitamin D (either
inactive or active form) alone, calcium and vitamin D together,
antiresorptive drugs (bisphosphonate, Rank-ligand inhibitor
etc.), anabolic agents (parathyroid hormone analogue), and
other drugs (calcitonin nasal spray, strontium ranelate). The
number of patients who adhered to each treatment at a follow
up period of 12 months is displayed in Table 2 and is shown to
be 8 (10.7%), 43 (57.3%), 17(22.7%), 5(6.7%) and 4 (5.3%)
respectively. No cases of osteonecrosis of the jaw or atypical
femoral fracture were reported.
At follow up examination of patients in this project, it was
seen that bone mineral density follow up was done in 36 pa-
tients (48%) compared to previously being done in only 34
patients (28.3%). After the project it was seen that there was a
100% rate of evaluation of patients for fracture risk.We compared the current data with a previous study
(Tanawat A. et al., 2015) that collected data regarding fragility
hip fractures of patients occurring before the implementation
of the FLS in Police General Hospital, as seen in Tables 1 and
2. It can be seen that the demographic data between 2 groups
has no statistically significant difference. We found statisti-
cally significant decreasing secondary fracture rates from 30%
to 0% (P < 0.0001) and increasing post-injury BMD follow up
from 28.3% to 48% (P ¼ 0.0053) and increased post-injury
osteoporotic medication administration from 40.8% to 80%
(P ¼ 0.0148) after participation in this project. However, the
1st year mortality rate change was not significant (P ¼ 0.731).
5. Discussion
According to a recent study done prior to the FLS project
by Jennings LA et al., out of 51,346 patients who were
hospitalized for osteoporotic hip fracture, only 7% received
an antiresorptive or bone forming medication [13]. From the
data of Tanawat A. et al. studying the population of patients
in Police General Hospital, it was found that 1st year mor-
tality rate, secondary fracture occurrence and follow up
of bone mineral density were 9.2%, 30% and 28.3%
respectively. It was also seen that osteoporotic treatment
1 year after fracture with calcium and Vitamin D, non-
bisphosphonate drugs and bisphosphonate drugs were
20.8%, 15%, and 5% respectively. Follow-up after fracture
at 1 year was found to be less than 2% [9]. Underdiagnosis
Fig. 2. Flow chart of Police General Hospital Fracture Liaison service.
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problem and is prevalent worldwide.
A study after the FLS project that was done by Kristen M.B
Huntjens et al. showed that in nonvertebral osteoporotic
fracture patients who participated in Fracture Liaison Service
had a decreased mortality rate of approximately 35% (95% CI
0.53e0.79) and a secondary fracture rate of 56% (95% CI
0.25e0.79) [10]. This is consistent with another study per-
formed by N. Dehamchia-Rehailia et al. that displayed a bone
mineral density follow up rate of 100%, administration of
osteoporotic medication rate of 70%, and fracture risk
assessment of more than 90% [12].
A FLS is likely to result in an environment of improved co-
ordination of multi-disciplinary care with better communica-
tion between healthcare professionals. The comprehensive
assessment and inspection of routine laboratory examinations
and medical history that an osteoporosis nurse specialistcarries out may also contribute to the identification of sec-
ondary diseases and comorbidities. It has been shown to
improve fracture care.
After 1 year of implementing our FLS project, we found the
post-injury bone mineral density follow up of patients
increasing from 28.3% to 48%, administration of osteoporotic
treatment increasing to 80% with no evidence of secondary
fracture, and all were statistically significant. We managed to
evaluate all patients participating in this study for fracture risk.
From the data, it can be seen that this project provides evi-
dence of the potential success of a secondary fracture pre-
vention program, including improved assessment and
treatment rates.
Although 1-year mortality rate was 10.7%, this was not
statistically significant, however it was lower than the rate seen
in a study performed by Center JR et al., which displayed a
20% mortality rate 1 year after osteoporotic hip fracture [14].
Table 1
Demographic data.






Male 32 (26.7%) 12 (16%)
Female 88 (73.3%) 63 (84%)
Age (year) 0.784
 80 68 (57%) 41 (54.7%)
> 80 52 (43%) 34 (45.3%)
Underlying disease 0.115
Hypertension 84 (70%) 56 (74.7%)
Diabetes mellitus 21 (17.5%) 27 (36%)
Dyslipidemia 33 (27.5%) 21 (28%)
Type of fracture 0.201
Neck of femur 55 (45.8%) 35 (46.7%)
Intertrochanteric 63 (52.5%) 38 (50.7%)
Greater trochanter 0 (0%) 2 (2.7%)
Type of treatment 0.603
Conservative 21 (17.5%) 11 (14.7%)
Operative 99 (82.5%) 64 (85.3%)
Fixation
Sliding hip screw 10 (8.3%) 7 (9.3%)
Nail 41 (34.2%) 25 (33.3%)
Multiple screw 3 (2.5%) 3 (4%)
Arthroplasty
Hemiarthroplasty 39 (32.5%) 27 (36%)
Total hip arthroplasty 4 (3.3%) 2 (2.7%)
Pre-injury BMD checking 8 (6.7%) 7 (9.3%) 0.4966
*P < 0.05 is significant.
Fig. 3. Pre-injury osteoporotic medication.
Table 2
Results before FLS project and after in a follow-up time period of 1 year.










Secondary fracture 36 (30%) 0 (0%) <0.0001
Post-injury osteoporotic medication 0.0148
No 71 (59.2%) 15 (20%)
Yes 49 (40.8%) 60 (80%)
Calcium alone 8 (10.7%)
Calcium and vitamin D 25 (20.8%) 43 (57.3%)
Antiresorptive 18 (15%) 17 (22.7%)
Anabolic 6 (5%) 5 (6.7%)
Other 4 (5.3%)
Post-injury BMD checking 34 (28.3%) 36 (48%) 0.0053
Fracture risk assessment No data 75 (100%) NA
*P < 0.05 is significant, NA e Not assessment.
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ducted by P. Wongtriratanachai et al. done in Chiang Mai,
Thailand, which displayed a 1st year mortality rate in hip
fracture of approximately 18e20% [5]. Because our study
included an elderly age group (average age was 79.7 years) the
patients had many underlying diseases and the cause of death
in most of the patients were not related to the fractures at all. Atotal of 8 patients were deceased at follow up, with a 33.3%
mortality rate for the male patients (4 out of 12 male patients
included in the study) and a 6.3% mortality rate for the female
patients (4 out of 63 female patients included in the study).
This clearly displays that male patients have a statistically
significantly higher mortality rate after osteoporotic hip frac-
ture when compared to female patients. These results are
similar to those seen in a report by Pia Nimann Kannedaard
et al. [15], which displayed a substantially higher mortality
rate in male patients presenting with osteoporotic hip fracture
when compared to female patients, despite the fact that the
male patients were an average of 4 years younger than the
female patients at the time of initial fracture.
Even though the rate of drug administration had improved
from 40.8% to 80%, most of the patients (68%) were receiving
243T. Amphansap et al. / Osteoporosis and Sarcopenia 2 (2016) 238e243only calcium and/or vitamin D supplements due to the high cost
of other osteoporotic medications (antiresorptive and anabolic
drugs). This issue may be prevented if the cost of osteoporotic
medication is lowered so that all types of treatment are acces-
sible to patients of lower socio-economic status. Twenty percent
of patients discontinued osteoporosis treatment within the first
year. The main course of treatment discontinuation was non-
renewal of the prescription by the patient's attending physician.
Poor compliance with medication for chronic diseases is a
common concern in many elderly patients. Patients with an
inadequate understanding of their disease are more likely to be
noncompliant with their treatment. This project can help them
recognize the severity of their disease and improved outcomes
of long-term adherence to treatment.
Some strengths seen in this study include the following. This
study is the first of its kind in Thailand, with the FLS project
being implemented for the first time in Thailand here at Police
General Hospital. This study also had a 100% rate of evaluation
of fracture risk and ruling out secondary osteoporosis in all
patients participating in the project. In terms of fall prevention,
this project provided a liaison nurse to evaluate fall risk, a
physiologist to direct proper muscle balance training and
muscle strengthening, and a home visit team that was able to
give proper advice to the patients and their caregivers, as well as
evaluate risk of falling individualized for each elderly patients
that participated in the project. We believe that in addition to
treating osteoporosis medically, prevention of falling is very
important in decreasing the incidence of a secondary fracture.
The study displayed some limitations. The population size of
patients that were observed to compare between the two groups
in the same situation was small, but this limitation can be
revised by continuous data collection in further studies. The
population in the study was comprised of Thai nationals only.
Due to this, the findings might not be generalizable to other
racial or ethnic groups. The authors compared the current data
with a previous study (historical comparison) that collected data
regarding fragility hip fractures of patients occurring before the
implementation of the FLS in Police General Hospital.
6. Conclusion
Patients with recent hip fractures participating in the
Fracture Liaison service had a significantly higher post-injury
BMD follow up and osteoporotic medication administration
rates. This resulted in a lower risk of secondary fracture than
those who did not participate in the Fracture Liaison service at
a follow up time of one year.
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